Discover 1,672 paid clinical trials in Sandy Springs, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,672
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Get alerts for new trials in your area by subscribing now
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
for
ER-Positive HER2-Negative Breast Cancer
Location: Marietta GA, Kingwood TX
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07647328
Phase 3, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease
for
Autoimmune Diseases
Location: Peachtree Corners GA, Medley FL
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT06413511
Phase 1, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Atlanta GA, Jacksonville FL, Edgewood KY,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Atlanta GA, Nashville TN, Jacksonville FL, Durham NC,
Location: Atlanta GA, Birmingham AL, Corbin KY, Charlotte NC,
Sponsor: Paradigm Health
Sex: All
Age: 18+
Code: NCT06605404
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Atlanta GA, Athens GA, Chattanooga TN, Nashville TN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Atlanta GA, Farmington Hills MI, Montreal,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07541170
Phase 3, Recruiting
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Atlanta GA, Pinehurst NC, Wilson NC, Orange City FL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06899126
Phase 3, Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for
Non-small Cell Lung Cancer
Location: Atlanta GA, Marietta GA, Orange City FL, Fairfax VA,